SCHEMBL17640607

SCHEMBL17640607

c1ccc2c(c1)Oc1ccccc1N2c1ccc(-c2ccc(-c3noc(-c4ccc(N5c6ccccc6Oc6ccccc65)cc4)n3)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H4 Q96RI1 4/20 0.51
▸ RAB9A P51151 9/20 0.50
▸ SMN1; SMN2 Q16637 9/20 0.50
▸ NPC1 O15118 7/20 0.50
▸ HSD17B10 Q99714 4/20 0.50
▸ NFKB1 P19838 4/20 0.50
▸ NFKB2 Q00653 4/20 0.50
▸ RELA Q04206 4/20 0.50
▸ MAPT P10636 4/20 0.50
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ PKM P14618 2/20 0.45
▸ TP53 P04637 6/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ HPGD P15428 2/20 0.44
▸ S1PR1 P21453 1/20 0.44
▸ CYP1A2 P05177 1/20 0.43
▸ CA2 P00918 2/20 0.43
▸ CA9 Q16790 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17640527 0.99 NR1H4 (0.53) NR1H4RAB9ASMN1; SMN2NPC1HSD17B10
SCHEMBL17640544 0.96 NR1H4 (0.58) NR1H4RAB9ASMN1; SMN2NPC1HSD17B10
SCHEMBL17640537 0.96 NR1H4 (0.58) NR1H4RAB9ASMN1; SMN2NPC1HSD17B10
SCHEMBL17640609 0.90 NR1H4 (0.44) NR1H4RAB9ASMN1; SMN2NPC1HSD17B10
SCHEMBL17640623 0.89 NPC1 (0.44) NR1H4RAB9ASMN1; SMN2NPC1HSD17B10
SCHEMBL17640566 0.84 NR1H4 (0.66) NR1H4RAB9ASMN1; SMN2NPC1HSD17B10
SCHEMBL17640553 0.84 NR1H4 (0.66) NR1H4RAB9ASMN1; SMN2NPC1HSD17B10
SCHEMBL17640604 0.83 S1PR1 (0.40) NR1H4RAB9ASMN1; SMN2NPC1HSD17B10
SCHEMBL16271056 0.83 P2RX4 (0.39) SMN1; SMN2MAPTMEN1KMT2AKDM4E
SCHEMBL31059182 0.83 P2RX4 (0.39) SMN1; SMN2MAPTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency UDC IRELAND LIMITED (IE) 2019-06-25 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
WO-2016046350-A1 FLUORESCENT ORGANIC LIGHT EMITTING ELEMENTS HAVING HIGH EFFICIENCY BASF SE (DE) 2016-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency NR2E3, CRY1, ALDH1A2 NR1H4 3168/4885RAB9A 4709/4885SMN1; SMN2 3296/4885
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency NR2E3, CRY1, ALDH1A2 NR1H4 3168/4885RAB9A 4709/4885SMN1; SMN2 3296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback